These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3891442)

  • 1. Absorption of subcutaneously administered regular human and porcine insulin in different concentrations.
    Chantelau E; Sonnenberg GE; Rajab A; Römisch J; Berger M
    Diabete Metab; 1985 Apr; 11(2):106-10. PubMed ID: 3891442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An effective absorption behavior of insulin for diabetic treatment following intranasal delivery using porous spherical calcium carbonate in monkeys and healthy human volunteers.
    Haruta S; Hanafusa T; Fukase H; Miyajima H; Oki T
    Diabetes Technol Ther; 2003; 5(1):1-9. PubMed ID: 12725701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous use of regular human insulin (Novo): pharmacokinetics and continuous insulin infusion therapy.
    Sonnenberg GE; Kemmer FW; Cüppers HJ; Berger M
    Diabetes Care; 1983; 6 Suppl 1():35-9. PubMed ID: 6343035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porcine and human insulin absorption from subcutaneous tissues in normal and insulin-dependent diabetic subjects: a deconvolution-based approach.
    Nosadini R; De Kreutzenberg S; Duner E; Iori E; Avogaro A; Trevisan R; Fioretto P; Doria A; Merkel C; Cobelli C
    J Clin Endocrinol Metab; 1988 Sep; 67(3):551-9. PubMed ID: 3045144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic response to intravenous infusion of porcine and semi-synthetic human insulin in insulin-dependent diabetic men.
    Hale PJ; Brimble A; Crase J; Nattrass M
    Diabete Metab; 1986 Apr; 12(2):74-8. PubMed ID: 3522299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin delivery with meals. Plasma insulin profiles after bolus injection of human or porcine neutral insulin.
    Scott R; Smith J
    Diabete Metab; 1983; 9(2):95-9. PubMed ID: 6352353
    [No Abstract]   [Full Text] [Related]  

  • 7. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
    Hildebrandt P
    Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption kinetics of semisynthetic human insulin and biosynthetic (recombinant DNA) human insulin.
    Kemmer FW; Sonnenberg G; Cüppers HJ; Berger M
    Diabetes Care; 1982; 5 Suppl 2():23-8. PubMed ID: 6765535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation of insulin absorption during subcutaneous and peritoneal infusion in insulin-dependent diabetic patients with unsatisfactory long-term glycaemic response to continuous subcutaneous insulin infusion.
    Wredling R; Liu D; Lins PE; Adamson U
    Diabete Metab; 1991; 17(5):456-9. PubMed ID: 1752346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of potency of porcine insulin and semisynthetic human insulin at 3 dose levels using the euglycaemic clamp.
    Chisholm DJ; Kraegen EW; Hewett MJ; Lazarus L
    Horm Metab Res; 1983 Sep; 15(9):415-8. PubMed ID: 6357983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semisynthetic human insulin: pharmacokinetics and biological potency in healthy subjects in comparison with highly purified porcine insulin.
    Schulz B; Stöwhas H; Becker R; Steinicke A; Besch W
    Exp Clin Endocrinol; 1988 Mar; 92(3):307-13. PubMed ID: 3075554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between monocomponent human insulin U-40 and U-100 in CSII treatment of type 1 diabetics.
    Capani F; Carta Q; Vannini P; Ciaverella A; Consoli A; Fiocchi F; Monge L; Vitacolonna E; Sensi S
    Diabetes Res; 1986 Jul; 3(6):317-20. PubMed ID: 3530595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre- and postprandial hyperinsulinemia during insulin pump treatment; role of the subcutaneous bolus and basal infusion.
    Olsson PO; Jorfeldt L; Arnqvist H; Gerhardsson P
    Diabetes Res; 1991 Feb; 16(2):55-61. PubMed ID: 1817806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin.
    de Meijer PH; Lutterman JA
    Neth J Med; 1990 Feb; 36(1-2):4-12. PubMed ID: 2179752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Miscibility of human and bovine ultralente insulin with soluble insulin.
    Mühlhauser I; Broermann C; Tsotsalas M; Berger M
    Br Med J (Clin Res Ed); 1984 Dec; 289(6459):1656-7. PubMed ID: 6439364
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of premeal subcutaneous insulin infusion and injection in type I diabetic patients under continuous basal subcutaneous insulin delivery.
    Navascués I; Kerner W; Pfeiffer EF
    Life Support Syst; 1985; 3(3):263-7. PubMed ID: 3900596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous insulin substitution in insulin-dependent diabetes mellitus. Pharmacokinetic and pharmacodynamic studies.
    Olsson PO
    Acta Med Scand Suppl; 1987; 718():1-78. PubMed ID: 3321929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of subcutaneous regular insulin in type I diabetic patients: assessment using a glucose clamp technique.
    Gardner DF; Arakaki RF; Podet EJ; Nell LJ; Thomas JW; Field JB
    J Clin Endocrinol Metab; 1986 Sep; 63(3):689-94. PubMed ID: 3525600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion.
    Beylot M; Khalfallah Y; Laville M; Sautot G; Dechaud H; Serusclat P; Berthezene F; Riou JP; Mornex R
    Diabete Metab; 1987; 13(4):450-6. PubMed ID: 3315766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary insulin administration using the AERx system: physiological and physicochemical factors influencing insulin effectiveness in healthy fasting subjects.
    Farr SJ; McElduff A; Mather LE; Okikawa J; Ward ME; Gonda I; Licko V; Rubsamen RM
    Diabetes Technol Ther; 2000; 2(2):185-97. PubMed ID: 11469258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.